This document provides guidelines for the management of hyperbilirubinemia, or high bilirubin levels, in term newborn infants. It discusses the definition and causes of both physiologic and pathologic jaundice. Guidelines are given for prevention, screening, treatment with phototherapy or exchange transfusion, and identifying infants at risk of developing severe hyperbilirubinemia or kernicterus. Risk factors include jaundice in the first 24 hours or visible jaundice at discharge. Close follow-up is recommended for infants with risk factors.